Exodus Point Capital Management, LP Arrowhead Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 68,647 shares of ARWR stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,647
Previous 32,127
113.67%
Holding current value
$1.76 Million
Previous $863,000
127.46%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$392 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$317 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$219 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$168 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$106 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.71B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...